Canakinumab treatment in patients with active recurrent or chronic TNF-receptor associated syndrome (TRAPS): Efficacy and safety results from a proof of concept study
Crossref DOI link: https://doi.org/10.1186/1546-0096-13-S1-O59
Published Online: 2015-09-28
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lachmann, H
Cattalini, M
Obici, L
Barcellona, R
Speziale, A
Joubert, Y
Junge, G
Gattorno, M
Article History
First Online: 28 September 2015